AU6667290A - Pyridazine derivatives, process for their preparation and pharmaceutical compositions containing them - Google Patents

Pyridazine derivatives, process for their preparation and pharmaceutical compositions containing them

Info

Publication number
AU6667290A
AU6667290A AU66672/90A AU6667290A AU6667290A AU 6667290 A AU6667290 A AU 6667290A AU 66672/90 A AU66672/90 A AU 66672/90A AU 6667290 A AU6667290 A AU 6667290A AU 6667290 A AU6667290 A AU 6667290A
Authority
AU
Australia
Prior art keywords
preparation
pharmaceutical compositions
compositions containing
pyridazine derivatives
pyridazine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU66672/90A
Other versions
AU639043B2 (en
Inventor
Robert Boige-Grain
Roger Brodin
Jean Paul Kan
Dominique Olliero
Camille Georges Wermuth
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi SA
Original Assignee
Sanofi SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR8915137A external-priority patent/FR2654727B1/en
Application filed by Sanofi SA filed Critical Sanofi SA
Publication of AU6667290A publication Critical patent/AU6667290A/en
Application granted granted Critical
Publication of AU639043B2 publication Critical patent/AU639043B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/04—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having less than three double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/14—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/20—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU66672/90A 1989-11-17 1990-11-16 Pyridazine derivatives, process for their preparation and pharmaceutical compositions containing them Ceased AU639043B2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR8915137A FR2654727B1 (en) 1989-11-17 1989-11-17 PYRIDAZINE DERIVATIVES, PREPARATION METHOD AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME.
FR8915137 1989-11-17
FR9007533 1990-06-15
FR909007533A FR2663326B2 (en) 1989-11-17 1990-06-15 PYRIDAZINE DERIVATIVES, PREPARATION METHOD AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME.

Publications (2)

Publication Number Publication Date
AU6667290A true AU6667290A (en) 1991-05-23
AU639043B2 AU639043B2 (en) 1993-07-15

Family

ID=26227673

Family Applications (1)

Application Number Title Priority Date Filing Date
AU66672/90A Ceased AU639043B2 (en) 1989-11-17 1990-11-16 Pyridazine derivatives, process for their preparation and pharmaceutical compositions containing them

Country Status (21)

Country Link
EP (1) EP0429344B1 (en)
JP (1) JPH03170465A (en)
KR (1) KR0164599B1 (en)
AR (1) AR247557A1 (en)
AT (1) ATE143010T1 (en)
AU (1) AU639043B2 (en)
CA (1) CA2030133A1 (en)
DE (1) DE69028602T2 (en)
DK (1) DK0429344T3 (en)
ES (1) ES2094146T3 (en)
FI (1) FI101881B1 (en)
FR (1) FR2663326B2 (en)
GR (1) GR3021933T3 (en)
HK (1) HK1000597A1 (en)
HU (2) HU207852B (en)
IE (1) IE75697B1 (en)
IL (1) IL96384A (en)
LV (1) LV11972B (en)
NO (1) NO178967C (en)
NZ (1) NZ236107A (en)
PT (1) PT95902B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU638858B2 (en) * 1990-07-31 1993-07-08 Sanofi 6-alkylpyridazine derivatives, method of preparation and pharmaceutical compositions in which they are present

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2676444B1 (en) * 1991-05-16 1995-03-10 Sanofi Elf NOVEL AMINO-3 PYRIDAZINE DERIVATIVES ACTIVE IN THE CENTRAL NERVOUS SYSTEM, PREPARATION METHOD AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME.
CN1104430C (en) * 1996-01-15 2003-04-02 詹森药业有限公司 Angiogenesis inhibiting pyridazinamines
EP1042293B9 (en) * 1997-12-19 2008-09-03 Amgen Inc. Substituted pyridine and pyridazine compounds and their pharmaceutical use
US6528529B1 (en) 1998-03-31 2003-03-04 Acadia Pharmaceuticals Inc. Compounds with activity on muscarinic receptors
CA2442004A1 (en) 2001-03-23 2002-10-03 David J. Kyle Microbial feeds for aquaculture and agriculture
EP2275095A3 (en) 2005-08-26 2011-08-17 Braincells, Inc. Neurogenesis by muscarinic receptor modulation
EP2258358A3 (en) 2005-08-26 2011-09-07 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
KR20080081914A (en) 2005-12-07 2008-09-10 스미또모 가가꾸 가부시끼가이샤 Pyridazine compound and use thereof
FR2904314A1 (en) * 2006-07-26 2008-02-01 Centre Nat Rech Scient LINEAR PYRIDAZINIC AND PYRROLIC COMPOUNDS, METHODS OF OBTAINING AND APPLICATIONS
AR081626A1 (en) * 2010-04-23 2012-10-10 Cytokinetics Inc AMINO-PYRIDAZINIC COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND USE OF THE SAME TO TREAT CARDIAC AND SKELETIC MUSCULAR DISORDERS
WO2011133920A1 (en) 2010-04-23 2011-10-27 Cytokinetics, Inc. Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use
AR081331A1 (en) 2010-04-23 2012-08-08 Cytokinetics Inc AMINO- PYRIMIDINES COMPOSITIONS OF THE SAME AND METHODS FOR THE USE OF THE SAME
AR119731A1 (en) 2019-05-17 2022-01-05 Novartis Ag NLRP3 INFLAMASOME INHIBITORS
TW202204323A (en) * 2020-03-27 2022-02-01 日商安斯泰來製藥股份有限公司 Substituted pyridazine compound
WO2022166890A1 (en) * 2021-02-08 2022-08-11 南京明德新药研发有限公司 Substituted pyridazine phenol derivatives

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2510998B1 (en) * 1981-08-07 1986-01-10 Sanofi Sa NOVEL AMINO DERIVATIVES OF PYRIDAZINE, PROCESS FOR THEIR PREPARATION AND DRINKING ACTS THEREOF
FR2540113A1 (en) * 1983-01-27 1984-08-03 Sanofi Sa PYRIDAZINE DERIVATIVE ACIDS ACTIVE ON THE CENTRAL NERVOUS SYSTEM
DE3629929A1 (en) * 1986-09-03 1988-03-10 Thomae Gmbh Dr K NEW SULFONAMIDO-AETHYL COMPOUNDS, MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF
FR2642648B1 (en) * 1989-02-07 1991-06-21 Sanofi Sa USE OF ALKYL-5 PYRIDAZINE DERIVATIVES AS ACTIVE MEDICAMENTS ON THE CHOLINERGIC SYSTEM
PT93060B (en) * 1989-02-07 1995-12-29 Sanofi Sa METHOD FOR OBTAINING PYRIDAZINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU638858B2 (en) * 1990-07-31 1993-07-08 Sanofi 6-alkylpyridazine derivatives, method of preparation and pharmaceutical compositions in which they are present

Also Published As

Publication number Publication date
EP0429344B1 (en) 1996-09-18
IE904145A1 (en) 1991-05-22
NO904984D0 (en) 1990-11-16
PT95902A (en) 1991-09-13
HK1000597A1 (en) 1998-04-09
CA2030133A1 (en) 1991-05-18
FI905663A0 (en) 1990-11-15
NO178967B (en) 1996-04-01
DE69028602T2 (en) 1997-04-03
IL96384A (en) 1995-10-31
PT95902B (en) 1998-01-30
HU211351A9 (en) 1995-11-28
NZ236107A (en) 1992-10-28
HUT56078A (en) 1991-07-29
IL96384A0 (en) 1991-08-16
AU639043B2 (en) 1993-07-15
IE75697B1 (en) 1997-09-10
CA2030133C (en) 1991-05-18
FI101881B (en) 1998-09-15
HU207852B (en) 1993-06-28
DK0429344T3 (en) 1997-03-03
DE69028602D1 (en) 1996-10-24
EP0429344A1 (en) 1991-05-29
FI101881B1 (en) 1998-09-15
KR0164599B1 (en) 1999-01-15
FR2663326A2 (en) 1991-12-20
HU907178D0 (en) 1991-05-28
GR3021933T3 (en) 1997-03-31
KR910009672A (en) 1991-06-28
LV11972A (en) 1998-02-20
NO178967C (en) 1996-07-10
FI905663A (en) 1991-05-18
FR2663326B2 (en) 1992-10-16
LV11972B (en) 1998-04-20
AR247557A1 (en) 1995-01-31
ES2094146T3 (en) 1997-01-16
ATE143010T1 (en) 1996-10-15
JPH03170465A (en) 1991-07-24
NO904984L (en) 1991-05-21

Similar Documents

Publication Publication Date Title
AU8259691A (en) 3-amidopyrazole derivatives, process for preparing these and pharmaceutical compositions containing them
AU1252088A (en) Pharmaceutical composition, pharmaceutical granulate and process for their preparation
AU3224389A (en) Phenol substituted gem-diphosphonate derivatives, process for their preparation and pharmaceutical compositions containing them
AU6667290A (en) Pyridazine derivatives, process for their preparation and pharmaceutical compositions containing them
AU1161292A (en) Azabicydic and azatricydic derivatives, process and intermediates for their preparation and pharmaceutical compositions containing them
AU5212093A (en) Dihydro - and tetrahydro-isoquinolines, process for their preparation and pharmaceutical compositions containing same
AU4618989A (en) 2-iminobenzothiazoline derivatives, their preparation and pharmaceutical compositions containing them
AU2366088A (en) 2,2-dimethylchromene derivatives, process for their preparation and pharmaceutical compositions in which they are present
AU5493190A (en) Thieno-triazolo-diazepine derivatives, a preparation process of the same and therapeutic compositions containing them
HUT72319A (en) Epoxy-succinic acid derivatives, pharmaceutical compositions containing them and process for their preparation
IL94485A0 (en) Purine derivatives,process for their preparation and pharmaceutical compositions containing them
AU3112089A (en) Indoloquinoline system compounds, process for their preparation, and carcinostative composition containing them
AU7324087A (en) New immunosuppressant cyclodepsipeptides, process for their preparation and pharmaceutical compositions containing them
AU8917891A (en) Poly-aminopyrrolecarboxamido derivatives, processes for their preparation and pharmaceutical compositions containing them
AU617929B2 (en) Novel steroid derivatives, pharmaceutical compositions containing them and process for preparing same
AU631261B2 (en) Novel pyridine derivatives, pharmaceutical compositions containing them and process for preparing same
AU1563388A (en) New macrolide derivatives, process for the preparation thereof and pharmaceutical compositions containing them
EP0418020A3 (en) Cephalosporinderivatives, process for their preparation and pharmaceutical compositions
AU4756693A (en) 1-heteroarylazetidines and -pyrrolidines, process for their preparation and pharmaceutical compositions containing them
AU6016490A (en) New oxazolopyridine derivatives, process for preparing them and pharmaceutical compositions containing them
AU631407B2 (en) Magnesium folates, process for their preparation and pharmaceutical compositions
AU4373389A (en) New tylosin derivatives, process for the preparation thereof and pharmaceutical compositions containing them
AU5362890A (en) New macrolide derivatives, process for preparing them and pharmaceutical compositions containing them
AU1833888A (en) 2,2-dimethylchroman-3-ol derivatives, process for their preparation and pharmaceutical compositions in which they are present
AU621726B2 (en) New 5-acylbenzoxazolinone derivatives, processes for preparing them and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired